Annual Non Current Assets
$195.34 M
-$90.92 M-31.76%
31 December 2023
Summary:
Lyell Immunopharma annual long term assets is currently $195.34 million, with the most recent change of -$90.92 million (-31.76%) on 31 December 2023. During the last 3 years, it has fallen by -$95.39 million (-32.81%). LYEL annual non current assets is now -61.02% below its all-time high of $501.12 million, reached on 31 December 2021.LYEL Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$169.17 M
+$14.85 M+9.62%
30 September 2024
Summary:
Lyell Immunopharma quarterly long term assets is currently $169.17 million, with the most recent change of +$14.85 million (+9.62%) on 30 September 2024. Over the past year, it has dropped by -$38.97 million (-18.72%). LYEL quarterly non current assets is now -70.17% below its all-time high of $567.19 million, reached on 30 September 2021.LYEL Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Non Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -31.8% | -18.7% |
3 y3 years | -32.8% | -70.2% |
5 y5 years | - | - |
LYEL Non Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -61.0% | at low | -70.2% | +9.6% |
5 y | 5 years | -61.0% | +69.3% | -70.2% | +9.6% |
alltime | all time | -61.0% | +69.3% | -70.2% | +9.6% |
Lyell Immunopharma Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $169.17 M(+9.6%) |
June 2024 | - | $154.32 M(-3.6%) |
Mar 2024 | - | $160.06 M(-18.1%) |
Dec 2023 | $554.69 M(-14.8%) | $195.34 M(-6.1%) |
Sept 2023 | - | $208.13 M(-9.1%) |
June 2023 | - | $228.94 M(-10.6%) |
Mar 2023 | - | $256.05 M(-10.6%) |
Dec 2022 | $651.29 M | $286.27 M(-9.8%) |
Sept 2022 | - | $317.52 M(-10.5%) |
Date | Annual | Quarterly |
---|---|---|
June 2022 | - | $354.90 M(-20.5%) |
Mar 2022 | - | $446.40 M(-10.9%) |
Dec 2021 | $626.29 M(+1.4%) | $501.12 M(-11.6%) |
Sept 2021 | - | $567.19 M(+43.6%) |
June 2021 | - | $395.03 M(+47.7%) |
Mar 2021 | - | $267.45 M(-8.0%) |
Dec 2020 | $617.55 M(+40.3%) | - |
Dec 2020 | - | $290.73 M |
Dec 2019 | $440.26 M | - |
FAQ
- What is Lyell Immunopharma annual long term assets?
- What is the all time high annual non current assets for Lyell Immunopharma?
- What is Lyell Immunopharma annual non current assets year-on-year change?
- What is Lyell Immunopharma quarterly long term assets?
- What is the all time high quarterly non current assets for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly non current assets year-on-year change?
What is Lyell Immunopharma annual long term assets?
The current annual non current assets of LYEL is $195.34 M
What is the all time high annual non current assets for Lyell Immunopharma?
Lyell Immunopharma all-time high annual long term assets is $501.12 M
What is Lyell Immunopharma annual non current assets year-on-year change?
Over the past year, LYEL annual long term assets has changed by -$90.92 M (-31.76%)
What is Lyell Immunopharma quarterly long term assets?
The current quarterly non current assets of LYEL is $169.17 M
What is the all time high quarterly non current assets for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly long term assets is $567.19 M
What is Lyell Immunopharma quarterly non current assets year-on-year change?
Over the past year, LYEL quarterly long term assets has changed by -$38.97 M (-18.72%)